Investigational drug · Phase 2
EYU688
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Dengue.
Phase 2Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "EYU688"
First trial start
2024
Feb 20, 2024
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "EYU688", any sponsor or status.
Conditions studied
As listed on its trial records.
- Dengue
Largest trials
Live from ClinicalTrials.gov: studies naming "EYU688" as an intervention, largest first.
- A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue FeverPivotal-lookingRecruiting
Novartis PharmaceuticalsNovartis (NVS)
NCT06006559 · 108 participants (planned) · Start Feb 20, 2024 · Primary completion Jul 22, 2027
Drug: EYU688; Placebo · For: Dengue
Sites: Manaus, Brazil; Brasília, Brazil; Rio de Janeiro, Brazil · 27 sites in all
Newest research
PubMed records naming it or its code names, newest first.
- Orthoflaviviral Inhibitors in Clinical Trials, Preclinical In Vivo Efficacy Targeting NS2B-NS3 and Cellular Antiviral Activity via Competitive Protease Inhibition.
Cavina L, Bouma MJ, Gironés D, et al. · Molecules 2024
Also in development for Dengue
- ISLA101fenretinidePhase 21 trial
Island Pharmaceuticals · Dengue
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do. More from Novartis.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.